Physician
Moravek, Michael
Moravek, Michael was paid $360K by Medicaid between Aug 2021 and Dec 2024, across 72 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 14% of everything it billed.
33Billing provider infoMORAVEK, MICHAEL
CHICAGO, IL 60611
CHICAGO, IL 60611
33aNPI1144674508assigned 04/21/2016
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$360K
24GClaims95,285
24DCodes billed72
24AFirst – last monthAug 2021 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#91 of 398
Median peer was paid$66K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 58 | $988.09 | |
| 2022 | 140 | $3K | |
| 2023 | 19,855 | $74K | |
| 2024incomplete | 75,232 | $282K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14% | 17,366 | 10,682 | $50K |
| 80053 | Comprehensive metabolic panel | 11% | 7,854 | 5,439 | $40K |
| 83735 | 9.6% | 10,341 | 5,313 | $34K | |
| 84484 | 7.1% | 5,618 | 4,377 | $26K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.2% | 3,609 | 1,697 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.8% | 2,302 | 2,034 | $14K |
| 84703 | 3.7% | 3,815 | 3,388 | $13K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.6% | 2,154 | 2,069 | $13K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.4% | 455 | 431 | $12K |
| 85055 | 3.1% | 1,863 | 882 | $11K | |
| 87040 | 3.0% | 1,170 | 924 | $11K | |
| 83690 | 2.8% | 3,030 | 2,532 | $10K |
60 more codes
| 85027 | 2.4% | 2,970 | $9K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.8% | 1,071 | $6K |
| 84100 | 1.5% | 2,400 | $6K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 1,025 | $5K |
| 83880 | 1.4% | 852 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 839 | $5K |
| 86850 | 1.4% | 1,544 | $5K | |
| 82607 | 1.2% | 698 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 829 | $4K |
| 82746 | 1.0% | 659 | $4K | |
| 81001 | <1% | 2,495 | $4K | |
| 85610 | <1% | 1,751 | $3K | |
| 86901 | <1% | 1,790 | $3K | |
| 85379 | <1% | 858 | $3K | |
| 86900 | <1% | 1,792 | $3K | |
| 87081 | <1% | 874 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 430 | $3K |
| 82140 | <1% | 488 | $2K | |
| 82728 | <1% | 485 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 633 | $2K |
| 84702 | <1% | 410 | $2K | |
| 87186 | <1% | 378 | $2K | |
| 84466 | <1% | 385 | $2K | |
| 82550 | <1% | 533 | $2K | |
| 81003 | <1% | 1,487 | $2K | |
| 83540 | <1% | 490 | $2K | |
| 85730 | <1% | 484 | $1K | |
| 86140 | <1% | 625 | $1K | |
| 87070 | <1% | 418 | $1K | |
| 81025 | <1% | 494 | $1K | |
| 87075 | <1% | 240 | $1K | |
| 83615 | <1% | 435 | $1K | |
| 82570 | <1% | 478 | $1K | |
| 84439 | <1% | 240 | $1K | |
| 87205 | <1% | 503 | $925.75 | |
| 80069 | <1% | 198 | $826.89 | |
| 87641 | <1% | 134 | $799.50 | |
| 84550 | <1% | 368 | $759.94 | |
| 82248 | <1% | 368 | $732.92 | |
| 85652 | <1% | 534 | $696.92 | |
| 87634 | <1% | 92 | $552.00 | |
| 84156 | <1% | 383 | $458.41 | |
| 85520 | <1% | 94 | $410.05 | |
| 82247 | <1% | 163 | $386.90 | |
| 87147 | <1% | 186 | $347.20 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 58 | $342.65 |
| 85384 | <1% | 101 | $342.15 | |
| 84300 | <1% | 149 | $311.64 | |
| 85018 | <1% | 197 | $287.68 | |
| 85014 | <1% | 191 | $278.85 | |
| 88342 | <1% | 13 | $219.13 | |
| 82272 | <1% | 138 | $184.48 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 27 | $162.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $162.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 27 | $162.00 |
| 86308 | <1% | 57 | $129.60 | |
| 86870 | <1% | 16 | $96.00 | |
| 83935 | <1% | 33 | $77.65 | |
| 85045 | <1% | 58 | $75.71 | |
| 80178 | <1% | 13 | $41.99 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.